Cara Therapeutics Inc (NASDAQ:CARA)

1.69
BATS BZX Real-Time Price
As of 3:12pm ET
 +0.015 / +0.90%
Today’s Change
1.59
Today|||52-Week Range
12.81
-84.31%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Cara Therapeutics Inc have a median target of 17.00, with a high estimate of 25.00 and a low estimate of 3.00. The median estimate represents a +908.90% increase from the last price of 1.69.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Cara Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.51
Sales
$11.6M
Reporting Date
Nov 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.07%
 
 
 
 
 
 
Growthannually -19.68%
 
 
 
 
 
 

Sales

Growthquarterly 67.70%
 
 
 
 
 
 
Growthannually 3.70%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.